Keith S. Manchester - 01 Oct 2021 Form 3 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Keith Manchester
Issuer symbol
ROIV
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
3
Filing time
01 Oct 2021, 17:49:09 UTC
Previous filing
07 Jun 2021
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ROIV Common Shares 13,908,356 01 Oct 2021 Held by QVT Roiv Hldgs Onshore Ltd. F1
holding ROIV Common Shares 30,321,987 01 Oct 2021 Held by QVT Deferred Compensation Holdings Ltd. F1
holding ROIV Common Shares 5,616,260 01 Oct 2021 Held by QVT P&E Roiv Hldgs Ltd. F1
holding ROIV Common Shares 39,778,514 01 Oct 2021 Held by QVT Financial Investment Cayman Ltd. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Keith Manchester is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. He disclaims any beneficial ownership in the Roivant Sciences Ltd. common shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Remarks:

Exhibit 24 - Power of Attorney